TapImmune

TapImmune

TapImmune

TapImmune Inc. A biotechnology company specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease.
Founded
1999
Raised
$3.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$2,430,000
Venture capital - 2016
$1,275,000
Venture capital - 2010
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when TapImmune makes some noise.